Samuel Olivier 4

What Happened

• Samuel Olivier, a director of NewcelX Ltd. (NCEL), made purchases on 2026-04-27. He acquired 81,818 common shares at $2.75 each for a total of $225,000. The filing also shows an acquisition of 114,545 derivative securities (listed separately with no price reported).
• The transactions are reported as purchases (code P) and were made as open market or private purchases. The filing’s footnote clarifies that the combined purchase price for one common share plus an accompanying warrant was $2.75.

Key Details

• Transaction date(s): 2026-04-27
• Prices and value: 81,818 shares @ $2.75 = $225,000; 114,545 derivative shares reported with no price (N/A)
• Footnote: The $2.75 price represents the combined cost of one common share and one accompanying warrant (per filing footnote).
• Shares owned after transaction: Not specified in the information provided from the Form 4.
• Timeliness: Form 4 filed 2026-04-29 for trades on 2026-04-27 (appears timely under standard two-business-day reporting rules).

Context

• Purchases by insiders are generally viewed as a more informative signal than routine sales because they increase the insider’s ownership; these entries reflect purchases (not sales). The separate derivative line likely reflects warrants or other derivative instruments tied to the equity—footnote supports a warrant component. As always, insider buying does not guarantee future performance; use this alongside other research.